Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 5, 2025 • 5:00 PM ET

Date/Time Source News Release
01/02/2025 07:00 AM EST GlobeNewswire Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer
11/12/2024 07:00 AM EST GlobeNewswire Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants
11/11/2024 07:00 AM EST GlobeNewswire Avalo Therapeutics to Present at Upcoming Investor Conferences
11/07/2024 07:00 AM EST GlobeNewswire Avalo Reports Third Quarter 2024 Financial Results and Recent Business Updates
10/08/2024 07:00 AM EDT GlobeNewswire Avalo Announces First Patient Dosed in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa
09/04/2024 07:00 AM EDT GlobeNewswire Avalo Announces Participation in September Investor Conferences
08/12/2024 07:00 AM EDT GlobeNewswire Avalo Reports Second Quarter 2024 Financial Results and Provides Business Updates
07/16/2024 07:00 AM EDT GlobeNewswire Avalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officer
07/09/2024 07:00 AM EDT GlobeNewswire Avalo Therapeutics Announces Active IND for AVTX-009, an anti-IL-1? mAb, to Treat Hidradenitis Suppurativa
06/24/2024 04:01 PM EDT GlobeNewswire Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer
Page

Additional News

As of January 5, 2025 • 5:00 PM ET

Date/Time Source News Release
12/29/2024 04:06 PM EST Stock Traders Daily (AVTX) Proactive Strategies
12/08/2024 11:12 AM EST Stock Traders Daily Trading (AVTX) With Integrated Risk Controls
11/12/2024 09:09 AM EST SeekingAlpha Avalo Therapeutics receives $69.4M in proceeds from full exercise of private placement warrants
11/08/2024 04:36 AM EST US Earnings Reports Expected earnings - Avalo Therapeutics Inc.
11/07/2024 09:34 AM EST SeekingAlpha Avalo Therapeutics GAAP EPS of -$2.83, revenue of $0.25M
11/06/2024 08:02 AM EST Stock Traders Daily Where are the Opportunities in (AVTX)
09/13/2024 03:56 PM EDT Stock Traders Daily How To Trade (AVTX)
08/29/2024 04:22 AM EDT Stock Traders Daily Trading (AVTX) With Integrated Risk Controls
08/26/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Mon, Aug 26, 2024 as of 10.00 am ET
08/12/2024 07:26 AM EDT SeekingAlpha Avalo Therapeutics GAAP EPS of -$14.07
Page